Rate of Complete Spectacle Independence with a Trifocal Intraocular Lens: A Systematic Literature Review and Meta-Analysis.
Cataract surgery
PanOptix IOL
Presbyopia
Spectacle independence
Trifocal IOL
Journal
Ophthalmology and therapy
ISSN: 2193-8245
Titre abrégé: Ophthalmol Ther
Pays: England
ID NLM: 101634502
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
08
12
2022
accepted:
13
01
2023
pubmed:
7
2
2023
medline:
7
2
2023
entrez:
6
2
2023
Statut:
ppublish
Résumé
A systematic literature review and meta-analysis was conducted to identify and obtain a precise single summary estimate on complete spectacle independence after bilateral implantation of a trifocal intraocular lens (IOL) (AcrySof PanOptix, TFNTXX/TFATXX) for patients undergoing cataract surgery. A search was conducted in PubMed from January 2017 to September 2021. Relevant congress presentations were also searched to include data from completed studies not yet published. Search terms included the intervention (TFNTXX, TFATXX, PanOptix) and outcomes of interest (patient-reported spectacle independence rates). A Bayesian random-effects meta-analysis was conducted, providing a pooled estimate (median and its 95% credible interval) of complete spectacle independence rates among cataract surgery patients. Subgroup analyses evaluated spectacle independence after cataract surgery across different working distances (near, intermediate, far). Nineteen unique clinical studies were identified. Based on a meta-analysis of 13 studies (N = 513 patients), the complete spectacle independence rate after cataract surgery with TFNTXX/TFATXX IOL was 91.6% (95% credible interval 86.8-95.9%). Additionally, the spectacle independence rates at each focal point (N = 13 studies, 603 patients) were 89.6% (near), 96.3% (intermediate), and 95.9% (far). This meta-analysis demonstrated that at least nine out of ten patients receiving TFNTXX/TFATXX trifocal IOL during cataract surgery can expect to achieve complete spectacle independence. This study provides informative data for clinicians and patients to feel confident in the use of trifocal intraocular lenses as presbyopia-correcting IOLs that offer high rates of complete spectacle independence.
Identifiants
pubmed: 36745314
doi: 10.1007/s40123-023-00657-5
pii: 10.1007/s40123-023-00657-5
pmc: PMC10011212
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1157-1171Informations de copyright
© 2023. The Author(s).
Références
Freeman B. 2021 Premium Cataract Surgery Market Report. Market Scope. 2021.
Davidson RS, Dhaliwal D, Hamilton DR, et al. Surgical correction of presbyopia. J Cataract Refract Surg. 2016;42:920–30.
doi: 10.1016/j.jcrs.2016.05.003
pubmed: 27373400
Berdahl J, Bala C, Dhariwal M, et al. Patient and economic burden of presbyopia: a systematic literature review. Clin Ophthalmol. 2020;14:3439–50.
doi: 10.2147/OPTH.S269597
pubmed: 33116396
pmcid: 7588278
U.S. Food and Drug Administration. Alcon Laboratories, Inc. AcrySof
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88: 105906.
doi: 10.1016/j.ijsu.2021.105906
pubmed: 33789826
Sterne JA, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. Bmj. 2019;366 :l4898. https://www.bmj.com/content/366/bmj.l4898
Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. Bmj. 2016;355 :i4919. https://www.bmj.com/content/355/bmj.i4919
Sutton AJ, Abrams KR. Bayesian methods in meta-analysis and evidence synthesis. Stat Methods Med Res. 2001;10(4):277–303.
doi: 10.1177/096228020101000404
pubmed: 11491414
Sturtz S, Ligges U, Gelman A. R2WinBUGS: a package for running WinBUGS from R. J Stat Softw. 2005;12:1–16.
doi: 10.18637/jss.v012.i03
Brooks SP, Gelman A. General methods for monitoring convergence of iterative simulations. J Comput Graph Stat. 1998;7(4):434–55.
Ang R, Villarrubia A, Palomino C, et al. Depth of focus, visual outcomes, and spectacle independence of a new diffractive presbyopia-correcting intraocular lens. Paper presented at: European Society of Cataract and Refractive Surgeons; October 2, 2020; Dublin, Ireland.
Blehm C, Potvin R. Reported patient satisfaction and spectacle independence following bilateral implantation of the PanOptix
doi: 10.2147/OPTH.S323337
Chang J. Early clinical outcome of a trifocal intraocular lens in Asian eyes. Paper presented at: American Society of Cataract and Refractive Surgery; July 23, 2021; Las Vegas, Nevada, USA.
Cochener B, Boutillier G, Lamard M, et al. A comparative evaluation of a new generation of diffractive trifocal and extended depth of focus intraocular lenses. J Refract Surg. 2018;34(8):507–14.
doi: 10.3928/1081597X-20180530-02
pubmed: 30089179
Espaillat A, Coelho C, Batista MJM, et al. Predictors of photic phenomena with a trifocal IOL. Clin Ophthalmol (Auckland, NZ). 2021;15:495.
doi: 10.2147/OPTH.S282469
Ferreira T. Comparison of refractive and visual outcomes of three presbyopia-correcting intraocular lenses. Paper presented at: European Society of Cataract and Refractive Surgeons; October 8, 2021; Amsterdam, Netherlands.
García-Pérez JL, Gros-Otero J, Sánchez-Ramos C, et al. Short term visual outcomes of a new trifocal intraocular lens. BMC Ophthalmol. 2017;17(1):1–9.
doi: 10.1186/s12886-017-0462-y
Hamdi IM. Subjective perception of trifocal IOL performance, including toric models. Clin Ophthalmol (Auckland, NZ). 2019;13:1955.
doi: 10.2147/OPTH.S223062
Hovanesian JA, Jones M, Allen Q. The PanOptix trifocal IOL vs the ReSTOR 2.5 active focus and ReSTOR 3.0-add multifocal lenses: a study of patient satisfaction, visual disturbances, and uncorrected visual performance. Clin Ophthalmol (Auckland, NZ). 2021;15:983.
doi: 10.2147/OPTH.S285628
Kim MJ, Chung TY, Lee K, et al. Visual outcomes and safety after bilateral implantation of a trifocal presbyopia correcting intraocular lens in a Korean population: a prospective single-arm study. BMC Ophthalmol. 2020;20(1):1–11.
doi: 10.1186/s12886-020-01549-z
Mencucci R, Favuzza E, Caporossi O, et al. Comparative analysis of visual outcomes, reading skills, contrast sensitivity, and patient satisfaction with two models of trifocal diffractive intraocular lenses and an extended range of vision intraocular lens. Graefes Arch Clin Exp Ophthalmol. 2018;256(10):1913–22.
doi: 10.1007/s00417-018-4052-3
pubmed: 29980919
Modi S, Lehmann R, Maxwell A, et al. Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens. Ophthalmology. 2021;128(2):197–207.
doi: 10.1016/j.ophtha.2020.07.015
pubmed: 33004211
Modi S. A prospective, randomized comparison of bilaterally implanted extended depth of focus lenses and trifocal intraocular lenses. Paper presented at: American Society of Cataract and Refractive Surgery; July 23, 2021; Las Vegas, Nevada, USA.
Monaco G, Gari M, Di Censo F, et al. Visual performance after bilateral implantation of 2 new presbyopia-correcting intraocular lenses: trifocal versus extended range of vision. J Cataract Refract Surg. 2017;43(6):737–47.
doi: 10.1016/j.jcrs.2017.03.037
pubmed: 28732606
Nattis A. Evaluation of visual outcomes and patient satisfaction with trifocal intraocular lens implantation. Presented at: American Society of Cataract and Refractive Surgery; July 23, 2021; Las Vegas, Nevada, USA.
Ramamurthy D, Vasavada A, Padmanabhan P, et al. Clinical outcomes after bilateral implantation of a trifocal presbyopia-correcting intraocular lens in an Indian population. Clin Ophthalmol (Auckland, NZ). 2021;15:213.
doi: 10.2147/OPTH.S279001
Shatz AC, Potvin R. Spectacle independence and quality of vision after bilateral implantation of a trifocal intraocular lens. Clin Ophthalmol (Auckland, NZ). 2021;15:2545.
doi: 10.2147/OPTH.S318203
Tran DB, Owyang A, Hwang J, et al. Visual acuity, quality of vision, and patient-reported outcomes after bilateral implantation with a trifocal or extended depth of focus intraocular lens. Clin Ophthalmol (Auckland, NZ). 2021;15:403.
doi: 10.2147/OPTH.S295503
Zhang G. A prospective, comparative study of the vison outcomes between a trifocal IOL and an extended depth of focus IOL among Chinese population. Presented at: Asia-Pacific Academy of Ophthalmology Congress; September 5, 2021; virtual congress.
Berdahl J, Bala C, Dhariwal M, et al. A cost-benefit analysis comparing trifocal intraocular lens (IOL) with monofocal IOL from patient perspective in the USA. Paper presented at: American Society of Cataract and Refractive Surgery; July 23, 2021; Las Vegas, Nevada, USA.
Haidich A-B. Meta-analysis in medical research. Hippokratia. 2010;14(Suppl 1):29.
pubmed: 21487488
pmcid: 3049418